Progesterone receptor membrane component-1 regulates hepcidin biosynthesis.

Iron homeostasis is tightly regulated by the membrane iron exporter ferroportin and its regulatory peptide hormone hepcidin. The hepcidin/ferroportin axis is considered a promising therapeutic target for the treatment of diseases of iron overload or deficiency. Here, we conducted a chemical screen in zebrafish to identify small molecules that decrease ferroportin protein levels. The chemical screen led to the identification of 3 steroid molecules, epitiostanol, progesterone, and mifepristone, which decrease ferroportin levels by increasing the biosynthesis of hepcidin. These hepcidin-inducing steroids (HISs) did not activate known hepcidin-inducing pathways, including the BMP and JAK/STAT3 pathways. Progesterone receptor membrane component-1 (PGRMC1) was required for HIS-dependent increases in hepcidin biosynthesis, as PGRMC1 depletion in cultured hepatoma cells and zebrafish blocked the ability of HISs to increase hepcidin mRNA levels. Neutralizing antibodies directed against PGRMC1 attenuated the ability of HISs to induce hepcidin gene expression. Inhibiting the kinases of the SRC family, which are downstream of PGRMC1, blocked the ability of HISs to increase hepcidin mRNA levels. Furthermore, HIS treatment increased hepcidin biosynthesis in mice and humans. Together, these data indicate that PGRMC1 regulates hepcidin gene expression through an evolutionarily conserved mechanism. These studies have identified drug candidates and potential therapeutic targets for the treatment of diseases of abnormal iron metabolism.

[1]  C. Farquhar,et al.  Luteal phase support for assisted reproduction cycles. , 2015, The Cochrane database of systematic reviews.

[2]  J. Shuster,et al.  Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone. , 2014, American journal of physiology. Endocrinology and metabolism.

[3]  E. Nemeth,et al.  Hepcidin and Iron Homeostasis during Pregnancy , 2014, Nutrients.

[4]  Y. Liu,et al.  Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells* , 2014, Molecular & Cellular Proteomics.

[5]  Yan-zhong Chang,et al.  Sex Differences in Iron Status and Hepcidin Expression in Rats , 2014, Biological Trace Element Research.

[6]  S. Rivella,et al.  IDENTIFICATION OF ERYTHROFERRONE AS AN ERYTHROID REGULATOR OF IRON METABOLISM , 2014, Nature Genetics.

[7]  J. Pru,et al.  Non-canonical progesterone signaling in granulosa cell function. , 2014, Reproduction.

[8]  R. Peterson,et al.  The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6. , 2014, Blood.

[9]  T. Ganz,et al.  Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin , 2014, Hepatology.

[10]  P. Vandenabeele,et al.  The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems , 2013, BMC Pharmacology and Toxicology.

[11]  D. Bowden,et al.  Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study. , 2013, Blood.

[12]  C. Enns,et al.  Iron regulation by hepcidin. , 2013, The Journal of clinical investigation.

[13]  T. Travison,et al.  Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells , 2013, Aging cell.

[14]  S. Milstein,et al.  An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. , 2013, Blood.

[15]  Lei Wang,et al.  Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. , 2012, Gene.

[16]  T. Ganz,et al.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. , 2012, Blood.

[17]  C. Newton,et al.  Hepcidin demonstrates a biphasic association with anemia in acute Plasmodium falciparum malaria , 2012, Haematologica.

[18]  J. Peluso,et al.  Evidence for a genomic mechanism of action for progesterone receptor membrane component-1 , 2012, Steroids.

[19]  T. Tamaki,et al.  Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes , 2012, PloS one.

[20]  S. Meydani,et al.  Obesity during Pregnancy and Fetal Iron Status: is Hepcidin the link? , 2012, Journal of Perinatology.

[21]  M. Lidonnici,et al.  Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. , 2012, Blood.

[22]  S. Abramson,et al.  17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. , 2012, Endocrinology.

[23]  Herbert Y. Lin,et al.  Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation , 2012, American journal of hematology.

[24]  M. Fleseriu,et al.  Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[25]  Thomas G. Smith,et al.  Regulation of hepcidin expression at high altitude. , 2012, Blood.

[26]  Elizabeta Nemeth,et al.  Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. , 2011, The Journal of clinical investigation.

[27]  R. Evstatiev,et al.  Iron sensing and signalling , 2011, Gut.

[28]  C. López-Otín,et al.  Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. , 2011, Blood.

[29]  L. Kiemeney,et al.  Serum hepcidin: reference ranges and biochemical correlates in the general population. , 2011, Blood.

[30]  D. Scadden,et al.  Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. , 2011, Blood.

[31]  E. Neufeld.  Update on iron chelators in thalassemia. , 2010, Hematology. American Society of Hematology. Education Program.

[32]  J. Barton,et al.  How I treat hemochromatosis. , 2010, Blood.

[33]  A. Meng,et al.  Interruption of cenph Causes Mitotic Failure and Embryonic Death, and Its Haploinsufficiency Suppresses Cancer in Zebrafish* , 2010, The Journal of Biological Chemistry.

[34]  Shaohe Wang,et al.  Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos. , 2009, Blood.

[35]  L. Zon,et al.  Transferrin-a modulates hepcidin expression in zebrafish embryos. , 2009, Blood.

[36]  M. Roth,et al.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.

[37]  S. Vukicevic,et al.  BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.

[38]  Matthias W. Hentze,et al.  Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD , 2009, Journal of Molecular Medicine.

[39]  D. Girelli,et al.  Immunoassay for human serum hepcidin. , 2008, Blood.

[40]  K. Phoenix,et al.  Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. , 2008, The Journal of clinical endocrinology and metabolism.

[41]  R. Craven,et al.  Regulation of Iron Homeostasis Mediated by the Heme-binding Protein Dap1 (Damage Resistance Protein 1) via the P450 Protein Erg11/Cyp51* , 2007, Journal of Biological Chemistry.

[42]  H. Zischka,et al.  Membrane‐initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells , 2007, Glia.

[43]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[44]  Yong Liu,et al.  PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia , 2007, Neuroscience Letters.

[45]  M. Cahill.  Progesterone receptor membrane component 1: An integrative review , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[46]  M. Bard,et al.  Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. , 2007, Cell metabolism.

[47]  J. Peluso,et al.  Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. , 2006, The Journal of clinical endocrinology and metabolism.

[48]  Yi Fang Liu,et al.  Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. , 2006, Blood.

[49]  N. Andrews,et al.  Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.

[50]  J. Peluso,et al.  Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. , 2006, Endocrinology.

[51]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[52]  G. Vinson,et al.  Molecular identification of adrenal inner zone antigen as a heme‐binding protein , 2005, The FEBS journal.

[53]  M. Bard,et al.  Dap1p, a Heme-Binding Protein That Regulates the Cytochrome P450 Protein Erg11p/Cyp51p in Saccharomyces cerevisiae , 2005, Molecular and Cellular Biology.

[54]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[55]  P. Chow,et al.  The Effect of Megestrol Acetate on Growth of HepG2 Cells In vitro and In vivo , 2004, Clinical Cancer Research.

[56]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[57]  P. ten Dijke,et al.  Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.

[58]  B. Apgar,et al.  Using progestins in clinical practice. , 2000, American family physician.

[59]  M. Wehling,et al.  Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. , 1996, European journal of biochemistry.

[60]  J. Hanke,et al.  Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor , 1996, The Journal of Biological Chemistry.

[61]  C. Farquhar,et al.  Luteal phase support for assisted reproduction cycles (Review) , 2011 .

[62]  Cindy Farquhar,et al.  Luteal phase support for assisted reproduction cycles. , 2011, The Cochrane database of systematic reviews.

[63]  R. Craven,et al.  PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. , 2009, Pharmacology & therapeutics.

[64]  Charles C Hong,et al.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.

[65]  M. Hentze,et al.  STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. , 2007, Blood.

[66]  M. Cappellini,et al.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. , 2004, Haematologica.